A 12-page feature by Evan Osnos in The New Yorker, titled "The Future, Made in China," posits that China is aggressively positioning itself to dominate the industries of the future. The article suggests that China’s progress is the result of decades of consistent state investment, strategic industrial policy, and long-term diplomatic planning. According to the report, these efforts are now yielding significant results, potentially allowing China to lead in critical areas such as medical research, including the engineering of a cure for cancer.

The article frames this shift against the backdrop of American domestic policy. It suggests that the United States has been distracted by internal political "trivialities" and that specific trade, immigration, and budget policies enacted during the Trump administration have inadvertently created a vacuum that China is filling. The piece argues that America is currently in a state of "retreat," which has provided China with a strategic opening to accelerate its industrial goals. While the article highlights the competitive nature of this "race," it emphasizes that China's momentum is not merely a recent development but the culmination of a long-term national strategy. The report serves as a warning regarding the potential for China to surpass the U.S. in technological and scientific innovation if current trends continue.